Results 21 to 30 of about 244,949 (162)

Anti-VEGF Therapy and the Retina: An Update [PDF]

Journal of Ophthalmology, 2015
Ocular angiogenesis and macular oedema are major causes of sight loss across the world. Aberrant neovascularisation, which may arise secondary to numerous disease processes, can result in reduced vision as a result of oedema, haemorrhage, and scarring.
Tah, V, Orlans, H, Hyer, J, Casswell, E, Din, N, Sri Shanmuganathan, V, Ramskold, L, Pasu, S   +7 more
openaire   +4 more sources

Trends, geographical variation and factors associated with the use of anti-VEGF intravitreal injections in Portugal (2013–2018): a retrospective analysis of administrative data

BMJ Open, 2022
Aims The arrival of anti-vascular endothelial growth factor (anti-VEGF) therapies represented a treatment shift for several ophthalmological disorders and led to an increasing number of patients undergoing intravitreal injections.
Ana Patricia Marques, Rui Santana, António Filipe Macedo, Pedro Laires, João Victor Rocha, Marta Afonso-Silva, Ana Sofia Almeida, Julieta Fernandes, Marisa Pardal   +8 more
doaj   +1 more source

Anti-VEGF reduces inflammatory features in macular edema secondary to retinal vein occlusion [PDF]

International Journal of Ophthalmology, 2022
AIM: To investigate the anti-inflammatory effect of intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) in patients with macular edema secondary to retinal vein occlusion (RVO-ME).
Hai-Feng Qin, Fan-Jun Shi, Chao-Yang Zhang, Da-Wei Luo, Shi-Yue Qin, Jing Wu, Hai Xie, Jing-Ting Zhang, Qing-Hua Qiu, Kun Liu, Guo-Tong Xu, Guo-Xu Xu, Jing-Fa Zhang   +12 more
doaj   +1 more source

Anti-vascular endothelial growth factor monotherapy or combined with verteporfin photodynamic therapy for retinal angiomatous proliferation: a systematic review with meta-analysis

Frontiers in Pharmacology, 2023
Purpose: To assess functional and anatomical outcomes of intravitreal anti-Vascular Endothelial Growth Factor (anti-VEGF) monotherapy versus combined with verteporfin Photodynamic Therapy (PDT) for Retinal Angiomatous Proliferation (RAP).Methods: Studies
Matteo Fallico, Iacopo Macchi, Andrea Maugeri, Giuliana Favara, Martina Barchitta, Roberta Magnano San Lio, Antonella Agodi, Andrea Russo, Antonio Longo, Teresio Avitabile, Niccolò Castellino, Michele Reibaldi, Francesco Pignatelli, Maria Vadalà, Clara Patanè, Marcella Nebbioso, Vincenza Bonfiglio   +16 more
doaj   +1 more source

The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy

Drugs in Context, 2018
Diabetes is a major cause of visual impairment among workingage adults in the United States. The proliferative form of diabetic retinopathy is associated with severe vision loss (acuity
Yue Zhao, Rishi P Singh
doaj   +1 more source

Comparison of Intravitreal Anti-VEGF Agents With Laser Photocoagulation for Retinopathy of Prematurity of 1,627 Eyes in China

Frontiers in Medicine, 2022
PurposeTo compare the efficacies and treatment outcomes of intravitreal anti-VEGF agents and laser therapy in retinopathy of prematurity (ROP).MethodsA retrospective, non-randomized, comparative study of patients diagnosed with type 1 ROP or aggressive ...
Dandan Linghu, Dandan Linghu, Dandan Linghu, Yong Cheng, Yong Cheng, Yong Cheng, Xuemei Zhu, Xuemei Zhu, Xuemei Zhu, Xun Deng, Xun Deng, Xun Deng, Hong Yin, Hong Yin, Hong Yin, Yanrong Jiang, Yanrong Jiang, Yanrong Jiang, Mingwei Zhao, Mingwei Zhao, Mingwei Zhao, Xiaoxin Li, Xiaoxin Li, Xiaoxin Li, Xiaoxin Li, Jianhong Liang, Jianhong Liang, Jianhong Liang   +27 more
doaj   +1 more source

Anti-Scg3 Gene Therapy to Treat Choroidal Neovascularization in Mice

Biomedicines, 2023
Neovascular age-related macular degeneration (nAMD) with choroidal neovascularization (CNV) is a leading cause of blindness in the elderly in developed countries.
Chengchi Huang, Liyang Ji, Avinash Kaur, Hong Tian, Prabuddha Waduge, Keith A. Webster, Wei Li   +6 more
doaj   +1 more source

Modulated anti-VEGF therapy under the influence of lipid metabolizing proteins in Age related macular degeneration: a pilot study

Scientific Reports, 2022
Age-related macular degeneration (AMD) is a devastating retinal disease that results in irreversible vision loss in the aged population. The complex genetic nature and degree of genetic penetrance require a redefinition of the current therapeutic ...
Kaushal Sharma, Priya Battu, Ramandeep Singh, Suresh Kumar Sharma, Akshay Anand   +4 more
doaj   +1 more source

Intravitreal anti-vascular endothelial growth factor, laser photocoagulation, or combined therapy for diabetic macular edema: A systematic review and network meta-analysis

Frontiers in Endocrinology, 2023
PurposeTo conduct a network meta-analysis (NMA) comparing the efficacy of anti-vascular endothelial growth factor (VEGF) therapy alone versus laser photocoagulation (LP) therapy alone or anti-VEGF therapy combined with LP therapy for diabetic macular ...
Jiasheng Chen, Jiasheng Chen, Haowei Wang, Haowei Wang, Weiqiang Qiu, Weiqiang Qiu   +5 more
doaj   +1 more source

Antivascular endothelial growth factor for macular oedema secondary to retinal vein occlusion: a systematic review and meta-analysis

BMJ Open Ophthalmology, 2022
Purpose To evaluate the efficacy and safety of antivascular endothelial growth factor (anti-VEGF) agents in treating macular oedema due to retinal vein occlusion (RVO-ME).Methods Studies of randomised controlled trials were searched in PubMed, EMBASE ...
Chao Zhang, Shanshan Xu, Zhihui Song, Guangyao Li   +3 more
doaj   +1 more source